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Abstract
Objective: The aim of this study was to evaluate periodontal disease as a predictor of chronic
kidney disease (CKD) stage in older adults.
Methods: A total of 1159 adults aged 65 to 80 years and diagnosed with periodontal disease and
CKD (stages 1, 2, and 3) were randomly selected for a cross-sectional study. Periodontal status
was assessed using the Community Periodontal Index of Treatment Needs (CPITN) and CKD
was staged using the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
(NKF-KDOQI) guidelines.
Results: In patients with stage 1 CKD, the odds ratios (ORs) (95% confidence intervals [CIs]) for
CPITN-1, CPITN-2, CPITN-3, and CPITN-4 were 1.13 (0.83–1.55), 1.47 (1.13–1.81), 1, and 1,
respectively. In patients with stage 2 CKD, the ORs (95% CIs) for CPITN-1, CPITN-2, CPITN-3,
and CPITN-4 were 1.49 (1.14–1.93), 1.37 (1.02–1.78), 3.07 (2.81–3.25), and 3.65 (3.49–3.71),
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respectively. In patients with stage 3 CKD, the ORs (95% CIs) for CPITN-1, CPITN-2, CPITN-3,
and CPITN-4 were 1, 1, 4.61 (4.47–5.21), and 5.23 (5.14–5.47), respectively.
Conclusion: The highest CPITN values (CPITN-3 and CPITN-4) were associated with CKD
stages 2 and 3. Thus, periodontal disease may be associated with progression of CKD.
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Introduction
Periodontal disease is characterized by the
destruction of the connective tissues of the
periodontium and alveolar bone. Local
symptoms include edema, erythema, gingi-
val enlargement or recession, bleeding, sup-
puration, dental mobility, dental crowding,
deep pockets, bone loss, and dental exfoli-
ation. Periodontal disease is associated with
systemic cardiovascular pathologies, diabe-
tes, and chronic renal disease. Periodontitis
affects 11.2% of the world’s population,
making it the sixth most common disease
in humans.1 In some regions, the prevalence
of periodontal disease is up to 52.5% of the
population. Thus, more specialized treat-
ments and greater investment in the treat-
ment of periodontal disease is required.2–6
Chronic kidney disease (CKD), defined
as the loss of renal function, is a public
health problem related to premature mor-
tality with important social and economic
implications. Timely early diagnosis is nec-
essary for appropriate monitoring and
interventions.3 CKD presents at various
stages ranging from a slight decrease in glo-
merular function to end-stage chronic renal
failure. CKD can be staged according to the
National Kidney Foundation Kidney
Disease Outcomes Quality Initiative
(NKF-KDOQI) guidelines.4,5 Recent
studies have indicated that periodontal dis-
ease is an important risk factor for various
systemic pathologies including diabetes6
and CKD. Both the presence and severity
of periodontal disease may be associated
with CKD.7–9 Diabetes may be clinically
manifested in the oral cavity through
inflammation of the periodontal ligament
and gingival bleeding. Furthermore, the
presence of periodontal disease is associated
with higher risk of morbidity and mortality
related to cardiovascular and kidney dis-
ease.6 Although periodontal disease can
result from infection by multiple bacterial
species, certain microorganisms such as
Gram-negative bacilli have been implicated
in the onset and progression of CKD, espe-
cially in patients with impaired immunity
against bacteria and viruses. Thus, it is
important to identify associations between
periodontal disease and CKD stage.
Epidemiological data have documented a
population CKD prevalence of 20.7%; indi-
viduals aged 65 years and older are the most
affected.3 It is possible that periodontal dis-
ease could precede progression of CKD.
Thus, it is important to identify high-risk
groups in whom progression of CKD
could lead to severe sequelae such as renal
failure10–13 and death.14–17 Timely diagnosis
of periodontal disease in patients with CKD
may inform clinical decision making.
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The Community Periodontal Index of
Treatment Needs (CPITN) is a periodontal
index that evaluates periodontal conditions
such as periodontal bleeding, supragingival
and subgingival calculus, periodontal pock-
ets 4 to 5 mm, and deep pockets 6 mm.
This study aimed to identify associations
between periodontal condition and CKD
stage and to determine whether periodontal
disease could be used as a predictor of
CKD stage.
Methodology
This was a cross-sectional study. Patients
were randomly selected from a population
diagnosed with periodontal disease and
stage 1, 2, and 3 CKD according to the
STROBE guidelines.18 The study was con-
ducted according to the principles outlined
in the Declaration of Helsinki, and
the study protocol was approved by the
Institutional Review Board of the
Geriatric Military Hospital, Lima, Peru.
All participants provided written informed
consent. Patients were categorized into
three CKD stages according to the NKF-
KDOQI guidelines4,5 as follows: CKD
stage 1, glomerular filtration rate (GFR)
90 mL/minute/1.73 m2, negative protein-
uria, blood pressure 120 to 129 (systolic)
and 80 to 84 (diastolic); CKD stage 2,
GFR 60 to 89 mL/minute/1.73 m2, micro-
albuminuria, blood pressure 130 to 129
(systolic) and 85 to 89 (diastolic); and
CKD stage 3, GFR 30 to 59 mL/minute/
1.73 m2, proteinuria <1 g/24 hours, blood
pressure 140 to 159 (systolic) and 90 to 99
(diastolic). Participants were aged 65 to 80
years and were of both sexes. Comorbidities
included hypertension and diabetes melli-
tus. We excluded patients with neoplasms
and severely compromising systemic
conditions.
Periodontal status was assessed using the
CPITN. The CPITN is a screening proce-
dure for assessing periodontal status and
treatment needs and is rated on a four-
point scale as follows: 1, gingival bleeding
after gentle probing of the tooth surfaces; 2,
supragingival and subgingival calculus; 3,
4- to 5-mm periodontal deep pockets; and
4, periodontal deep pockets 6mm.
Clinical data were obtained within a 36-
month period. Periodontal status and
CKD stage were evaluated in all study par-
ticipants. Logistic regression analyses were
used to calculate odds ratios (ORs) and
95% confidence intervals (CIs).
Results
A total of 1159 patients diagnosed with
periodontal disease and CKD were enrolled
in the study. The association between CKD
stage and CPITN status was stronger in
patients aged 73 to 80 years compared
with those aged 65 to 72 years (OR 3.74,
95% CI 3.49–3.97, p< 0.001). The associa-
tion between CKD stage and CPITN status
did not depend on sex (OR 1.25, 95% CI
0.96–1.67). Among comorbidities, both
hypertension (OR 4.78, 95% CI 4.20–5.13,
p< 0.001) and diabetes mellitus (OR 6.89,
95% CI 6.74–6.96, p< 0.001) were associat-
ed with stronger CKD stage-CPITN status
associations (Table 1).
A total of 722 patients had CKD stage 1.
Among patients with CKD stage 1, the ORs
(95% CIs) for CPITN-1, CPITN-2,
CPITN-3, and CPITN-4 were 1.13
(0.83–1.55), 1.47 (1.13–1.81), 1, and 1,
respectively. None of these associations
were statistically significant. A total of 288
patients had CKD stage 2. Among patients
with CKD stage 2, the ORs (95% CIs) for
CPITN-1, CPITN-2, CPITN-3, and
CPITN-4 were 1.49 (1.14–1.93), 1.37
(1.02–1.78), 3.07 (2.81–3.25), and 3.65
(3.49–3.71), respectively. All of these asso-
ciations were statistically significant
(p<0.05), with CPITN-3 and CPITN-4
showing the strongest associations. A total
of 149 patients had CKD stage 3. Among
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patients with CKD stage 3, the ORs (95%
CIs) for CPITN-1, CPITN-2, CPITN-3,
and CPITN-4 were 1, 1, 4.61 (4.47–5.21),
and 5.23 (5.14–5.47), respectively. The asso-
ciations with CPITN-3 and CPITN-4 were
statistically significant (p<0.05) (Table 2).
Discussion
In this study, we analyzed associations
between periodontal status and CKD
stage in patients aged 65 to 80 years with
periodontal disease and CKD. Adults older
than 73 years showed a stronger association
between periodontal disease and CDK (OR
3.74, 95% CI 3.49–3.97). Our findings in
this study agree with those of other
authors,11–15 who identified a higher preva-
lence of periodontal disease in older adults.
This situation represents a public health
problem and places adults over 65 years
of age at a 44% risk of acquiring periodon-
titis. Periodontitis is a risk factor for CKD.
A population of Mexican-Americans with
impaired renal function was identified as
having twice the risk of periodontal disease
compared with healthy individuals.16,17
Likewise, in a study conducted in adults
Table 2. Associations between periodontal status (CPITN values) and stages of CKD.
CKD stage n (%)
CPITN value OR (95% CI)
CPITN-1 CPITN-2 CPITN-3 CPITN-4
CKD stage 1 722 (62.3) 1.13 1.47 1 1
(0.83–1.55) (1.13–1.81)
CKD stage 2 288 (24.8) 1.49 1.37 3.07 3.65
(1.14–1.93) (1.02–1.78) (2.81–3.25) (3.49–3.71)
CKD stage 3 149 (12.9) 1 1 4.61 5.23
(4.47–5.21) (5.14–5.47)
CKD, chronic kidney disease; OR, odds ratio; CI, confidence interval; CPITN, Community Periodontal Index of Treatment
Needs.
Table 1. Characteristics of periodontal disease and CKD in the study population.




65–72 642 (55.4) 1
73–80 517 (44.6) 3.74 (3.49–3.97)
Sex >0.05
Female 625 (53.9) 1
Male 534 (46.1) 1.25 (0.96–1.67)
Hypertension <0.001
Yes 876 (75.6) 4.78 (4.20–5.13)
No 283 (24.4) 1
Diabetes mellitus <0.001
Yes 752 (64.9) 6.89 (6.74–6.96)
No 407 (35.1) 1
CKD, chronic kidney disease; OR, odds ratio; CI, confidence interval; PD, periodontal disease.
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75 years or older in Japan, the authors
observed decreased renal function as well
as periodontitis.11 It is possible that peri-
odontal disease is a risk factor for the devel-
opment of CKD. In our study, men had
slightly but not statistically significantly
stronger associations between periodontal
status and CKD stage than women (OR
1.25, 95% CI 0.96–1.67). These findings
agree with those of other authors.12,14 Our
results suggest the presence of conditioning
risk factors for CKD. In our study, we
observed that patients with hypertension
showed stronger associations between peri-
odontal status and CKD (OR 4.78, 95% CI
4.20–5.13). Similarly, patients with diabetes
mellitus showed stronger associations
between periodontal status and CKD [OR
6.89, 95% CI 6.74–6.96). According to
reports from the World Health
Organization, exposures that lead to CKD
may be more frequent among older men. In
addition, other factors such as family histo-
ry of diabetes, arterial hypertension, and
chronic inflammation may play a role.5,6
The most disadvantaged populations
would have higher risks of developing
CKD (for instance, elderly patients with
associated pathologies).14–17
Among patients with CKD stage 1,
CPITN-1 (OR 1.13, 95% CI 0.83–1.55)
and CPITN-2 (OR 1.47, 95% CI 1.13–
1.81) showed non-significant associations
with CKD, while CPITN-3 (OR 1) and
CPITN-4 (OR 1) showed no association
with CKD. Among patients with CKD
stage 2, CPITN-1 (OR 1.49, 95% CI 1.14–
1.93) and CPITN-2 (OR 1.37, 95% CI
1.02–1.78) showed non-significant associa-
tions with CKD. By contrast, CPITN-3
(OR 3.07, 95% CI 2.81–3.25) and CPITN-
4 (OR 3.65, 95% CI 3.49–3.71) showed
moderate associations with CKD. Among
patients with CKD stage 3, CPITN-1 (OR
1) and CPITN-2 (OR 1) showed no associ-
ation with CKD. By contrast, CPITN-3
(OR 4.61, 95% CI 4.47–5.21) and CPITN-
4 [OR 5.23, 95% CI 5.14–5.47) showed
moderate associations with CKD. The
CPITN measured periodontal conditions,
and attained higher values along with
increasing stages of CKD. Our results indi-
cate that the clinical characteristics of peri-
odontal disease may be related to the stage
of CKD, and could be used to predict pro-
gression of CKD. Studies evaluating the
association between periodontal disease
and chronic use of corticosteroids in
patients with CKD could confirm this asso-
ciation.13 Better understanding of these
associations would inform clinical manage-
ment of periodontal disease in patients
with CKD.
Epidemiological studies suggest that the
highest prevalence of CKD occurs in older
adult populations. In this study, older
adults were considered a vulnerable group
appropriate for evaluating the periodontal
disease-CKD association. Comorbid condi-
tions such as diabetes mellitus could influ-
ence the progression of periodontal disease.
The most common periodontal status
among patients with CKD stage 1 was
CPITN-1 (bleeding after probing). Most
patients with CKD stage 2 had supra-
subgingival calculus. In patients with
CDK stage 3, many patients had periodon-
tal pockets of 4 to 5 mm and periodontal
pockets 6 mm. Patients with stage 3 CKD
had the highest CPITN values, suggesting
that periodontal pathology increases in
patients with CKD as a function of the
time of exposure to the disease.
Periodontitis is a risk factor for CKD.
Reports indicate that 30% to 60% of the
United States population had a high prob-
ability of developing moderate periodonti-
tis.9,10 According to the results of our study,
the association between periodontal disease
(CPITN) and the stages of CKD varied by
stage. We identified an association between
periodontal disease and CKD as described
previously by other authors.8,14 Thus, peri-
odontal disease may be a risk factor for
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decreased renal function.15–17 The previous
evidence supporting an association between
periodontitis and CKD did not provide
information regarding the association
between periodontal disease and CKD
stage. The results of our study showed
that in all patients evaluated, the clinical
characteristics of periodontal disease were
associated with the stages of CKD. These
associations may be used to predict CKD
progression.
Conclusions
In this study, periodontal disease (CPITN-1
to CPITN-4) and CKD stage (1–3) were
evaluated. The highest CPITN values
(CPITN-3 and CPITN-4) were associated
with CKD stage 2 and CKD stage 3.
These results suggest that progression of
periodontal disease was associated with
more advanced stages of CKD.
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